^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Bladder Cancer
    Drug:cisplatin (DNA synthesis inhibitor) +
    doxorubicin hydrochloride (Topoisomerase II inhibitor) +
    ifosfamide (Bifunctional alkylating agent) +
    etoposide IV (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Bladder cancer: Neoadjuvant chemotherapy…ifosfamide + doxorubicin with etoposide + cisplatin...